Interplay between miRNAs and human diseases
Abstract
MicroRNAs (miRNAs) are endogenous, non-coding RNAs, which have evoked a great deal of interest due to their importance in many aspects of homeostasis and diseases. MicroRNAs are stable and are essential components of gene regulatory networks. They play a crucial role in healthy individuals and their dysregulations have also been implicated in a wide range of diseases, including diabetes, cardiovascular disease, kidney disease, and cancer. This review summarized the current understanding of interactions between miRNAs and different diseases and their role in disease diagnosis and therapy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
miRNAs are small (~22 nt) non-coding RNAs involved in diverse physiological and developmental processes, and their dysregulation leads to several diseases including cancer.
“miRNAs are small (~22 nt) non-coding RNAs involved in diverse physiological and developmental processes, and their dysregulation lead to several diseases including cancer (14–16).”
From Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma (2019) · cites this paper as [15]
Aberrant expression of miRNAs is associated with many human diseases.
“Aberrant expression of miRNAs is associated with many human diseases (19, 20).”
From Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation (2018) · cites this paper as [20]
Cites
3 retracted
RETRACTED AND REPLACED: microRNA involvement in human cancer
Iorio, M. V., & Croce, C. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs140 · Cited by 568 · see citing works
RetractedXu, C., Lu, Y., Pan, Z., Chu, W., Luo, X., Lin, H., Xiao, J., Shan, H., Wang, Z., & Yang, B. (2007) · Journal of Cell Science · doi:10.1242/jcs.010728 · Cited by 439 · see citing works
RetractedXiao, J., Luo, X., Lin, H., Zhang, Y., Lu, Y., Wang, N., Zhang, Y., Yang, B., & Wang, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700015200 · Cited by 234 · see citing works
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714 · see citing works
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068 · see citing works
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948 · see citing works
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969 · see citing works
Identification of Novel Genes Coding for Small Expressed RNAs
Lagos-Quintana, M., Rauhut, R., Lendeckel, W., & Tuschl, T. (2001) · Science · doi:10.1126/science.1064921 · Cited by 4,956 · see citing works
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,931 · see citing works
miRBase: microRNA sequences, targets and gene nomenclature
Griffiths‐Jones, S. (2005) · Nucleic Acids Research · doi:10.1093/nar/gkj112 · Cited by 4,713 · see citing works
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008) · Cell Research · doi:10.1038/cr.2008.282 · Cited by 4,560 · see citing works
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,096 · see citing works
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053 · see citing works
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023 · see citing works
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAsPreprint
Yi, R., Qin, Y., Macara, I. G., & Cullen, B. R. (2003) · Genes & Development · doi:10.1101/gad.1158803 · Cited by 3,020 · see citing works
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation
Chen, J., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., Conlon, F. L., & Wang, D.-Z. (2005) · Nature Genetics · doi:10.1038/ng1725 · Cited by 2,763 · see citing works
Nuclear Export of MicroRNA Precursors
Lund, E., Güttinger, S., Calado, Â., Dahlberg, J. E., & Kutay, U. (2003) · Science · doi:10.1126/science.1090599 · Cited by 2,705 · see citing works
MicroRNA maturation: stepwise processing and subcellular localization
Lee, Y., Jeon, K., Lee, J., Kim, S., & Kim, V. N. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf476 · Cited by 2,468 · see citing works
Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, T., Yatabe, Y., Nagino, M., Nimura, Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0637 · Cited by 2,356 · see citing works
A pancreatic islet-specific microRNA regulates insulin secretion
Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., MacDonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., et al. (2004) · Nature · doi:10.1038/nature03076 · Cited by 2,102 · see citing works
MicroRNA-133 controls cardiac hypertrophy
Carè, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., Bang, M., Segnalini, P., Gu, Y., Dalton, N. D., et al. (2007) · Nature Medicine · doi:10.1038/nm1582 · Cited by 1,775 · see citing works
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Iorio, M. V., & Croce, C. M. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100209 · Cited by 1,738 · see citing works
The Diverse Functions of MicroRNAs in Animal Development and Disease
Kloosterman, W. P., & Plasterk, R. H. A. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.09.009 · Cited by 1,714 · see citing works
Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J. A., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,648 · see citing works
Reduced accumulation of specific microRNAs in colorectal neoplasia.
Michael, M., Connor, S. M. O., Pellekaan, N. V. H., Young, G. P., & James, R. J. (2003) · PubMed · Cited by 1,576 · see citing works
Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis
Zhao, Y. B., Samal, E., & Srivastava, D. P. (2005) · Nature · doi:10.1038/nature03817 · Cited by 1,556 · see citing works
Hayashita, Y., Osada, H., Tatematsu, Y., Yamada, H., Yanagisawa, K., Tomida, S., Yatabe, Y., Kawahara, K., Sekido, Y., & Takahashi, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2352 · Cited by 1,511 · see citing works
Serum MicroRNAs Are Promising Novel Biomarkers
Gilad, S., Meiri, E., Yogev, Y., Benjamin, S., Lebanony, D., Yerushalmi, N., Benjamin, H., Kushnir, M., Cholakh, H., Melamed, N., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003148 · Cited by 1,349 · see citing works
Saito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., Coetzee, G. A., & Jones, P. A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.020 · Cited by 1,328 · see citing works
Lewis, G. F., Carpentier, A. C., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,328 · see citing works
Widespread microRNA repression by Myc contributes to tumorigenesis
Chang, T.-C., Yu, D., Lee, Y., Wentzel, E. A., Arking, D. E., West, K. M., Dang, C. V., Thomas‐Tikhonenko, A., & Mendell, J. T. (2007) · Nature Genetics · doi:10.1038/ng.2007.30 · Cited by 1,326 · see citing works
The role of microRNA genes in papillary thyroid carcinoma
He, H., Jażdżewski, K., Li, W., Liyanarachchi, S., Nagy, R. S., Volinia, S., Calin, G. A., Liu, C., Franssila, K., Suster, S. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509603102 · Cited by 1,212 · see citing works
Murakami, Y., Yasuda, T., Saigo, K., Urashima, T., Toyoda, H., Okanoue, T., & Shimotohno, K. (2005) · Oncogene · doi:10.1038/sj.onc.1209283 · Cited by 1,148 · see citing works
Extensive modulation of a set of microRNAs in primary glioblastoma
Ciafrè, S. A., Galardi, S., Mangiola, A., Ferracin, M., Liu, C.-G., Sabatino, G., Negrini, M., Maira, G., Croce, C. M., & Farace, M. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.030 · Cited by 1,096 · see citing works
A microRNA DNA methylation signature for human cancer metastasis
Lujambio, A., Calin, G. A., Villanueva, A., Ropero, S., Sánchez‐Céspedes, M., Blanco, D., Montuenga, L. M., Rossi, S., Nicoloso, M. S., Faller, W. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803055105 · Cited by 1,078 · see citing works
Getting to the Root of miRNA-Mediated Gene Silencing
Eulálio, A., Huntzinger, E., & Izaurralde, E. (2008) · Cell · doi:10.1016/j.cell.2007.12.024 · Cited by 1,071 · see citing works
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster
Dews, M., Homayouni, A., Yu, D., Murphy, D. A., Sevignani, C., Wentzel, E. A., Furth, E. E., Lee, W. M., Enders, G. H., Mendell, J. T., et al. (2006) · Nature Genetics · doi:10.1038/ng1855 · Cited by 1,049 · see citing works
MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb
Xiao, C., Calado, D. P., Galler, G. R., Thai, T., Patterson, H. C., Wang, J., Rajewsky, N., Bender, T. P., & Rajewsky, K. (2007) · Cell · doi:10.1016/j.cell.2007.07.021 · Cited by 1,041 · see citing works
microRNAs exhibit high frequency genomic alterations in human cancer
Zhang, L., Huang, J., Yang, N., Greshock, J. D., Megraw, M. S., Giannakakis, A., Liang, S., Naylor, T. L., Barchetti, A., Ward, M. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508889103 · Cited by 1,032 · see citing works
The Drosophila MicroRNA Mir-14 Suppresses Cell Death and Is Required for Normal Fat Metabolism
Xu, P., Vernooy, S. Y., Guo, M., & Hay, B. A. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00250-1 · Cited by 1,006 · see citing works
MicroRNAs 103 and 107 regulate insulin sensitivity
Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., Heim, M. H., & Stoffel, M. (2011) · Nature · doi:10.1038/nature10112 · Cited by 1,000 · see citing works
MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms
Zeng, Y., Yi, R., & Cullen, B. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630797100 · Cited by 923 · see citing works
Extensive post-transcriptional regulation of microRNAs and its implications for cancerPreprint
Thomson, J. M., Newman, M., Parker, J. S., Morin-Kensicki, E. M., Wright, T., & Hammond, S. M. (2006) · Genes & Development · doi:10.1101/gad.1444406 · Cited by 858 · see citing works
miR-133 and miR-30 Regulate Connective Tissue Growth Factor
Duisters, R. F. J. J., Tijsen, A. J., Schroen, B. L. M., Leenders, J. J., Lentink, V., van der Made, I., Hérias, V., van Leeuwen, R. E. W., Schellings, M. W. M., Barenbrug, P. J. C., et al. (2008) · Circulation Research · doi:10.1161/circresaha.108.182535 · Cited by 816 · see citing works
Aravin, A. A., Nm, N., Tulin, A. V., Vagin, V. V., Rozovsky, Y. M., & Gvozdev, V. A. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00299-8 · Cited by 796 · see citing works
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues
Liu, C.-G., Calin, G. A., Meloon, B., Gamliel, N., Sevignani, C., Ferracin, M., Dumitru, C. D., Shimizu, M., Zupo, S., Dono, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403293101 · Cited by 778 · see citing works
A custom microarray platform for analysis of microRNA gene expression
Thomson, J. M., Parker, J. S., Perou, C. M., & Hammond, S. M. (2004) · Nature Methods · doi:10.1038/nmeth704 · Cited by 742 · see citing works
<i>miR-375</i> maintains normal pancreatic α- and β-cell mass
Poy, M. N., Hausser, J., Trajkovski, M., Braun, M., Collins, S., Rorsman, P., Zavolan, M., & Stoffel, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810550106 · Cited by 740 · see citing works
Kato, M. V., Zhang, J., Wang, M., Lanting, L. L., Yuan, H., Rossi, J. J., & Natarajan, R. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611192104 · Cited by 700 · see citing works
Rayner, K. J., Sheedy, F. J., Esau, C. C., Hussain, F. N., Temel, R. E., Parathath, S., van Gils, J. M., Rayner, A. J., Chang, A. N., Suarez, Y., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57275 · Cited by 690 · cited 2× · see citing works
“In gene regulation, miRNAs provide promising therapeutic targets that have been demonstrated in animal models (Montgomery et al., 2011; Rayner et al., 2011; Romaine et al., 2015;Wahlquist et al., 2014).”
BackgroundCirculating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease
Corsten, M. F., Dennert, R., Jochems, S., Kuznetsova, T., Devaux, Y., Hofstra, L., Wagner, D. R., Staessen, J. A., Heymans, S., & Schroen, B. (2010) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.110.957415 · Cited by 677 · see citing works
IRE1α Cleaves Select microRNAs During ER Stress to Derepress Translation of Proapoptotic Caspase-2
Upton, J.-P., Wang, L., Han, D., Wang, E. S., Huskey, N. E., Lim, L., Truitt, M., McManus, M. T., Ruggero, D., Goga, A., et al. (2012) · Science · doi:10.1126/science.1226191 · Cited by 640 · see citing works
Therapeutic Inhibition of miR-208a Improves Cardiac Function and Survival During Heart Failure
Montgomery, R. L., Hullinger, T. G., Semus, H. M., Dickinson, B., Seto, A. G., Lynch, J. M., Stack, C., Latimer, P. A., Olson, E. N., & van Rooij, E. (2011) · Circulation · doi:10.1161/circulationaha.111.030932 · Cited by 602 · see citing works
MicroRNAs Add a New Dimension to Cardiovascular Disease
Small, E. M., Frost, R. J., & Olson, E. N. (2010) · Circulation · doi:10.1161/circulationaha.109.889048 · Cited by 594 · see citing works
TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN
Kato, M. V., Putta, S., Wang, M., Yuan, H., Lanting, L. L., Nair, I., Gunn, A., Nakagawa, Y., Shimano, H., Todorov, I., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1897 · Cited by 574 · see citing works
Mechanisms of microRNA-mediated gene regulation in animal cells
Nilsen, T. W. (2007) · Trends in Genetics · doi:10.1016/j.tig.2007.02.011 · Cited by 574 · see citing works
Circulating microRNAs as novel biomarkers for diabetes mellitus
Guay, C., & Regazzi, R. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.86 · Cited by 563 · see citing works
Kong, L., Zhu, J., Han, W., Jiang, X., Xu, M., Zhao, Y., Dong, Q., Pang, Z., Guan, Q., Gao, L., et al. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0226-0 · Cited by 529 · see citing works
Rapid Alteration of MicroRNA Levels by Histone Deacetylase Inhibition
Scott, G. K., Mattie, M. D., Berger, C. E., Benz, S. C., & Benz, C. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3632 · Cited by 493 · see citing works
MicroRNAs in cardiovascular disease: an introduction for clinicians
Romaine, S. P. R., Tomaszewski, M., Condorelli, G., & Samani, N. J. (2015) · Heart · doi:10.1136/heartjnl-2013-305402 · Cited by 479 · see citing works
Plasma miR-208 as a Biomarker of Myocardial Injury
Ji, X., Takahashi, R., Hiura, Y., Hirokawa, G., Fukushima, Y., & Iwai, N. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.125310 · Cited by 471 · see citing works
Kloosterman, W. P., Lagendijk, A. K., Ketting, R. F., Moulton, J. D., & Plasterk, R. H. A. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050203 · Cited by 461 · see citing works
Epigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancer
Lehmann, U., Hasemeier, B., Christgen, M., Müller, M., Römermann, D., Länger, F. P., & Kreipe, H. H. (2007) · The Journal of Pathology · doi:10.1002/path.2251 · Cited by 460 · see citing works
MicroRNA-181b regulates NF-κB–mediated vascular inflammation
Sun, X., Icli, B., Wara, A. K., Belkin, N., He, S., Kobzik, L., Hunninghake, G. M., Pinilla-Vera, M., Blackwell, T. S., Baron, R. M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61495 · Cited by 450 · see citing works
Epigenetic regulation of microRNA expression in colorectal cancer
Bandrés, E., Agirre, X., Bitarte, N., Ramírez, N., Zárate, R., Román‐Gómez, J., Prósper, F., & García‐Foncillas, J. (2009) · International Journal of Cancer · doi:10.1002/ijc.24638 · Cited by 438 · see citing works
Agre, P. C. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200510-109jh · Cited by 435 · see citing works
Karolina, D. S., Armugam, A., Subramaniam, T., Wong, M. T. K., Lim, S. C., Sum, C. F., & Jeyaseelan, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022839 · Cited by 434 · see citing works
Ouaamari, A. E., Baroukh, N., Martens, G. A., Lebrun, P., PIPELEERS, D. G., & OBBERGHEN, E. V. (2008) · Diabetes · doi:10.2337/db07-1614 · Cited by 430 · see citing works
Inhibition of miR-25 improves cardiac contractility in the failing heart
Wahlquist, C., Jeong, D., Rojas‐Muñoz, A., Kho, C., Lee, A. A., Mitsuyama, S., van Mil, A., Park, W. J., Sluijter, J. P. G., Doevendans, P. A., et al. (2014) · Nature · doi:10.1038/nature13073 · Cited by 412 · see citing works
Wang, Q., Wang, Y., Minto, A. W., Wang, J., Shi, Q., Li, X., & Quigg, R. J. (2008) · The FASEB Journal · doi:10.1096/fj.08-112326 · Cited by 398 · see citing works
Caporali, A., Meloni, M., Völlenkle, C., Bonci, D., Sala-Newby, G. B., Addis, R., Spinetti, G., Losa, S., Masson, R., Baker, A. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.952325 · Cited by 397 · see citing works
Epigenetic Silencing of the Myelopoiesis Regulator microRNA-223 by the AML1/ETO Oncoprotein
Fazi, F., Racanicchi, S., Zardo, G., Starnes, L. M., Mancini, M., Travaglini, L., Diverio, D., Ammatuna, E., Cimino, G. G., Lo‐Coco, F., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.09.020 · Cited by 381 · see citing works
microRNAs in Cardiovascular Diseases
Condorelli, G., Latronico, M. V. G., & Cavarretta, E. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.050 · Cited by 379 · see citing works
Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?
Weiler, J., Hunziker, J., & Hall, J. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302654 · Cited by 371 · see citing works
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA
Volinia, S., Galasso, M., Sana, M. E., Wise, T. F., Palatini, J., Huebner, K., & Croce, C. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200010109 · Cited by 357 · see citing works
miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes
Zhong, X., Chung, A. C. K., Chen, H., Dong, Y., Meng, X., Li, R., Yang, W., Hou, F., & Lan, H. Y. (2013) · Diabetologia · doi:10.1007/s00125-012-2804-x · Cited by 352 · see citing works
Podocyte-Selective Deletion of Dicer Induces Proteinuria and Glomerulosclerosis
Shi, S., Yu, L., Chiu, C., Sun, Y., Chen, J., Khitrov, G., Merkenschlager, M., Holzman, L. B., Zhang, W., Mundel, P., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008030312 · Cited by 349 · see citing works
miR-200a Prevents Renal Fibrogenesis Through Repression of TGF-β2 Expression
Wang, B., Koh, P., Winbanks, C. E., Coughlan, M. T., McClelland, A. D., Watson, A. M. D., Jandeleit-Dahm, K. A. M., Burns, W. C., Thomas, M. C., Cooper, M. E., et al. (2010) · Diabetes · doi:10.2337/db10-0892 · Cited by 346 · see citing works
Sun, Y. A. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh186 · Cited by 342 · see citing works
Mavrakis, K. J., Wolfe, A. L., Oricchio, E., Palomero, T., Keersmaecker, K. D., McJunkin, K., Zuber, J. A., James, T., Khan, A. A., Leslie, C. S., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2037 · Cited by 335 · see citing works
DNA methylation regulates microRNA expression
Han, L., Witmer, P. D., Casey, E. R., Valle, D. L., & Sukumar, S. V. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.8.4486 · Cited by 333 · see citing works
MicroRNA-124a Regulates Foxa2 Expression and Intracellular Signaling in Pancreatic β-Cell Lines*
Baroukh, N., Ravier, M. A., Loder, M. K., Hill, E. V., Bounacer, A., Scharfmann, R., Rutter, G. A., & Van Obberghen, E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611841200 · Cited by 326 · see citing works
Leaman, D. P., Chen, P., Fak, J. J., Yalçın, A., Pearce, M., Unnerstall, U., Marks, D. S., Sander, C., Tuschl, T., & Gaul, U. (2005) · Cell · doi:10.1016/j.cell.2005.04.016 · Cited by 322 · see citing works
Podocyte-Specific Deletion of Dicer Alters Cytoskeletal Dynamics and Causes Glomerular Disease
Harvey, S. J., Jarad, G., Cunningham, J. M., Goldberg, S., Schermer, B., Harfe, B. D., McManus, M. T., Benzing, T. R., & Miner, J. H. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008020233 · Cited by 319 · see citing works
Kent, O. A., Chivukula, R. R., Mullendore, M. E., Wentzel, E. A., Feldmann, G., Lee, K. H., Liu, S., Leach, S. D., Maitra, A., & Mendell, J. T. (2010) · Genes & Development · doi:10.1101/gad.1950610 · Cited by 310 · see citing works
MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment
Quiat, D., & Olson, E. N. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62876 · Cited by 302 · see citing works
Chen, T., Huang, Z., Wang, L., Wang, Y., Wu, F., Meng, S., & Wang, C. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp121 · Cited by 297 · see citing works
Podocyte-Specific Loss of Functional MicroRNAs Leads to Rapid Glomerular and Tubular Injury
Ho, J., Ng, K. H., Rosen, S., Dostal, A., Gregory, R. I., & Kreidberg, J. A. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008020162 · Cited by 293 · see citing works
MicroRNA-22 Regulates Cardiac Hypertrophy and Remodeling in Response to Stress
Huang, Z., Chen, J., Seok, H., Zhang, Z., Kataoka, M., Hu, X., & Wang, D.-Z. (2013) · Circulation Research · doi:10.1161/circresaha.112.300682 · Cited by 291 · see citing works
Nielsen, L. B., Wang, C., Sørensen, K., Bang‐Berthelsen, C. H., Hansen, L. B., Andersen, M.-L. M., Hougaard, P., Juul, A., Zhang, C., Pociot, F., et al. (2012) · Experimental Diabetes Research · doi:10.1155/2012/896362 · Cited by 289 · see citing works
Wang, X., Qian, R., Zhang, W., Chen, S., Jin, H., & Hu, R. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.05057.x · Cited by 271 · see citing works
Epigenetic Activation of Tumor Suppressor MicroRNAs in Human Cancer Cells
Saito, Y., & Jones, P. M. (2006) · Cell Cycle · doi:10.4161/cc.5.19.3340 · Cited by 270 · see citing works
MicroRNA turnover: when, how, and why
Rüegger, S., & Großhans, H. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.07.002 · Cited by 269 · see citing works
Implications of micro-RNA profiling for cancer diagnosis
Cummins, J. M., & Velculescu, V. E. (2006) · Oncogene · doi:10.1038/sj.onc.1209914 · Cited by 268 · see citing works
Long, J., Wang, Y., Wang, W., Chang, B. H., & Danesh, F. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.194969 · Cited by 265 · see citing works
Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients
Dai, Y., Sui, W., Lan, H., Yan, Q., Huang, H., & Huang, Y. (2008) · Rheumatology International · doi:10.1007/s00296-008-0758-6 · Cited by 265 · see citing works
MicroRNAs and chromosomal abnormalities in cancer cells
Calin, G. A., & Croce, C. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209910 · Cited by 262 · see citing works
Pescador, N., Pérez‐Barba, M., Ibarra, J. M., Anchuelo, A. C., Martínez-Larrad, M. T., & Serrano‐Ríos, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077251 · Cited by 259 · see citing works
Wang, B., Herman‐Edelstein, M., Koh, P., Burns, W. C., Jandeleit-Dahm, K. A. M., Watson, A. M. D., Saleem, M. A., Goodall, G. J., Twigg, S. M., Cooper, M. E., et al. (2010) · Diabetes · doi:10.2337/db09-1736 · Cited by 244 · see citing works
Balasubramanyam, M., Aravind, S., Gokulakrishnan, K., Paramasivam, P., Chandrakumar, S., Ranjani, H., & Mohan, V. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0727-3 · Cited by 238 · see citing works
Nesca, V., Guay, C., Jacovetti, C., Menoud, V., Peyot, M., Laybutt, D. R., Prentki, M., & Regazzi, R. (2013) · Diabetologia · doi:10.1007/s00125-013-2993-y · Cited by 234 · see citing works
MicroRNA Dysregulation in Diabetic Ischemic Heart Failure Patients
Greco, S., Fasanaro, P., Castelvecchio, S., D’Alessandra, Y., Arcelli, D., Donato, M. D., Malavazos, A. E., Capogrossi, M. C., Menicanti, L., & Martelli, F. (2012) · Diabetes · doi:10.2337/db11-0952 · Cited by 234 · see citing works
Tian, Z., Greene, A. S., Pietrusz, J. L., Matus, I. R., & Liang, M. (2008) · Genome Research · doi:10.1101/gr.6587008 · Cited by 223 · see citing works
Role of microRNAs in kidney homeostasis and disease
Chandrasekaran, K., Karolina, D. S., Sepramaniam, S., Armugam, A., Wintour, E. M., Bertram, J. F., & Jeyaseelan, K. (2012) · Kidney International · doi:10.1038/ki.2011.448 · Cited by 220 · see citing works
A microRNA cluster as a target of genomic amplification in malignant lymphoma
Tagawa, H., & Seto, M. (2005) · Leukemia · doi:10.1038/sj.leu.2403942 · Cited by 213 · see citing works
Suckau, L., Fechner, H., Chemaly, E. R., Krohn, S., Hadri, L., Kockskämper, J., Westermann, D., Bisping, E. H., Ly, H. Q., Wang, X., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.783852 · Cited by 211 · see citing works
CpG Island Hypermethylation of Tumor Suppressor microRNAs in Human Cancer
Lujambio, A. (2007) · Cell Cycle · doi:10.4161/cc.6.12.4408 · Cited by 211 · see citing works
miR‐1/miR‐206 regulate Hsp60 expression contributing to glucose‐mediated apoptosis in cardiomyocytes
Shan, Z., Lin, Q., Deng, C., Zhu, J.-N., Mai, L., Liu, J., Fu, Y., Liu, X., Li, Y.-X., Zhang, Y., et al. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.07.027 · Cited by 208 · see citing works
The role of microRNA in modulating myocardial ischemia-reperfusion injury
Ye, Y., Perez-Polo, J. R., Qian, J., & Birnbaum, Y. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00130.2010 · Cited by 206 · see citing works
Hypertension in Autosomal-Dominant Polycystic Kidney Disease
Ecder, T., & Schrier, R. W. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v121194 · Cited by 205 · see citing works
MicroRNAs: A new class of gene regulators
Guarnieri, D. J., & Dileone, R. (2008) · Annals of Medicine · doi:10.1080/07853890701771823 · Cited by 202 · see citing works
MicroRNA-29a Promotion of Nephrin Acetylation Ameliorates Hyperglycemia-Induced Podocyte Dysfunction
Lin, C., Lee, P., Hsu, Y., Lei, C., Ko, J., Chuang, P.-C., Huang, Y., Wang, S.-Y., Wu, S.-L., Chen, Y., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050527 · Cited by 193 · see citing works
Huang, R., Hu, G., Lin, B., Lin, Z., & Sun, C. (2010) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181ff46d7 · Cited by 189 · see citing works
Ohler, U., Yekta, S., Lim, L. P., Bartel, D. P., & Burge, C. B. (2004) · RNA · doi:10.1261/rna.5206304 · Cited by 189 · see citing works
The bantam Gene Regulates Drosophila Growth
Hipfner, D. R., Weigmann, K., & Cohen, S. M. (2002) · Genetics · doi:10.1093/genetics/161.4.1527 · Cited by 188 · see citing works
microRNAs and the regulation of glucose and lipid metabolism
Poy, M. N., Spranger, M., & Stoffel, M. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00775.x · Cited by 182 · see citing works
Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells
Neves, R. P., Scheel, C., Weinhold, S., Honisch, E., Iwaniuk, K. M., Trompeter, H., Niederacher, D., Wernet, P., Santourlidis, S., & Uhrberg, M. (2010) · BMC Research Notes · doi:10.1186/1756-0500-3-219 · Cited by 179 · see citing works
Recent Progress in HIV-Associated Nephropathy
Wyatt, C. M., Meliambro, K. A., & Klotman, P. E. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-041610-134224 · Cited by 174 · see citing works
Kato, M. V., Wang, L., Putta, S., Wang, M., Yuan, H., Sun, G., Lanting, L. L., Todorov, I., Rossi, J. J., & Natarajan, R. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.165027 · Cited by 165 · see citing works
Transforming growth factor‐β/ S mad signalling in diabetic nephropathy
Lan, H. Y. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05663.x · Cited by 157 · see citing works
Sepramaniam, S., Armugam, A., Lim, K. Y., Karolina, D. S., Swaminathan, P., Tan, J., & Jeyaseelan, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.144576 · Cited by 154 · see citing works
miR-195 regulates SIRT1-mediated changes in diabetic retinopathy
Mortuza, R., Feng, B., & Chakrabarti, S. (2014) · Diabetologia · doi:10.1007/s00125-014-3197-9 · Cited by 153 · see citing works
Urinary miR-21, miR-29, and miR-93: Novel Biomarkers of Fibrosis
Wang, G., Kwan, B. C., Lai, F. M., Chow, K. M., Li, P. K., & Szeto, C. (2012) · American Journal of Nephrology · doi:10.1159/000343452 · Cited by 152 · see citing works
The MicroRNA-Processing Enzyme Dicer Maintains Juxtaglomerular Cells
Sequeira-Lόpez, M. L. S., Weatherford, E. T., Borges, G. R., Monteagudo, M. C., Pentz, E. S., Harfe, B. D., Carretero, O. A., Sigmund, C. D., & Gómez, R. A. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009090964 · Cited by 149 · see citing works
Tran, U., Zakin, L., Schweickert, A., Agrawal, R., Döger, R., Blum, M., Robertis, E. M. D., & Wessely, O. (2010) · Development · doi:10.1242/dev.046045 · Cited by 146 · see citing works
Joglekar, M. V., Parekh, V. S., Mehta, S. S., Bhonde, R. R., & Hardikar, A. A. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.09.008 · Cited by 145 · see citing works
MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy
Simpson, K., Wonnacott, A., Fraser, D. J., & Bowen, T. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0724-8 · Cited by 139 · see citing works
Madrigal-Matute, J., Rotllan, N., Aranda, J. F., & Fernández-Hernando, C. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0322-z · Cited by 138 · see citing works
Bui, T. V., & Mendell, J. T. (2010) · Genes & Cancer · doi:10.1177/1947601910377491 · Cited by 137 · see citing works
miR-200b Precursor Can Ameliorate Renal Tubulointerstitial Fibrosis
Oba, S., Kumano, S., Suzuki, E., Nishimatsu, H., Takahashi, M., Takamori, H., Kasuya, M., Ogawa, Y., Sato, K., Kimura, K., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013614 · Cited by 134 · see citing works
Interplay between HIV-1 infection and host microRNAs
Sun, G., Li, H., Wu, X., Covarrubias, M., Scherer, L. J., Meinking, K., Luk, B. T., Chomchan, P., Alluin, J. V., Gombart, A. F., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr961 · Cited by 133 · see citing works
microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts.
Schulte, C., & Zeller, T. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-3652.2014.12.03 · Cited by 131 · see citing works
Increased expression of microRNA miR‐326 in type 1 diabetic patients with ongoing islet autoimmunity
Sebastiani, G., Grieco, F. A., Spagnuolo, I., Galleri, L., Cataldo, D., & Dotta, F. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1262 · Cited by 131 · see citing works
The Role of MicroRNAs in Diabetic Complications—Special Emphasis on Wound Healing
Moura, J., Børsheim, E., & Carvalho, E. (2014) · Genes · doi:10.3390/genes5040926 · Cited by 125 · see citing works
Low‐dose paclitaxel ameliorates fibrosis in the remnant kidney model by down‐regulating miR‐192
Sun, L., Zhang, D., Liu, F., Xiang, X., Ling, G., Xiao, L., Liu, Y., Zhu, X., Zhan, M., Yang, Y., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2961 · Cited by 124 · see citing works
Analytical challenges and technical limitations in assessing circulating MiRNAs
Mayr, M., & Zampetaki, A. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-02-0097 · Cited by 124 · see citing works
Izumchenko, E., Chang, X., Michailidi, C., Kagohara, L. T., Ravi, R. K., Paz, K., Brait, M., Hoque, M. O., Ling, S., Bedi, A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0110 · Cited by 124 · see citing works
GLP-1 and Amylin in the Treatment of Obesity
Jorsal, T., Rungby, J., Knop, F. K., & Vilsbøll, T. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0693-3 · Cited by 123 · see citing works
Pandey, P., Brors, B., Srivastava, P. K., Bott, A., Boehn, S. N. E., Groene, H.-J., & Gretz, N. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-624 · Cited by 123 · see citing works
Wong, L. L., Wang, J., Liew, O. W., Richards, M., & Chen, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040502 · Cited by 121 · see citing works
Kriegel, A. J., Fang, Y., Liu, Y., Tian, Z., Mladinov, D., Matus, I. R., Ding, X., Greene, A. S., & Liang, M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq718 · Cited by 117 · see citing works
MicroRNA-143/-145 in Cardiovascular Diseases
Wang, Z., Zhao, S.-P., & Zhao, Y. (2015) · BioMed Research International · doi:10.1155/2015/531740 · Cited by 111 · see citing works
Salas‐Pérez, F., Ethel Codner, D., Valencia, E., Pizarro, C., Carrasco, E., & Pérez‐Bravo, F. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.08.276 · Cited by 104 · see citing works
Shanmugam, N., Reddy, M. A., & Natarajan, R. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806322200 · Cited by 104 · see citing works
The regulation and function of micrornas in kidney diseases
Wei, Q., Mi, Q., & Dong, Z. (2013) · IUBMB Life · doi:10.1002/iub.1174 · Cited by 104 · see citing works
Murray, A. R., Chen, Q., Takahashi, Y., Zhou, K., Park, K., & Ma, J. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10921 · Cited by 102 · see citing works
Impaired DICER1 function promotes stemness and metastasis in colon cancer
Iliou, M. S., da Silva-Diz, V., Carmona, F. J., Ramalho-Carvalho, J., Heyn, H., Villanueva, A., Muñoz, P., & Esteller, M. (2013) · Oncogene · doi:10.1038/onc.2013.398 · Cited by 97 · see citing works
Sun, H., Li, Q.-W., Lv, X., Ai, J.-Z., Yang, Q.-T., Duan, J.-J., Bian, G.-H., Xiao, Y., Wang, Y.-D., Zhang, Z., et al. (2009) · Molecular Biology Reports · doi:10.1007/s11033-009-9861-3 · Cited by 89 · see citing works
Epigenetic silencing of miR-145-5p contributes to brain metastasis
Donzelli, S., Mori, F., Bellissimo, T., Sacconi, A., Casini, B., Frixa, T., Roscilli, G., Aurisicchio, L., Facciolo, F., Pompili, A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5930 · Cited by 86 · see citing works
Hennessy, E., CLYNES, M. M., Jeppesen, P. B., & O’Driscoll, L. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.116 · Cited by 76 · see citing works
Weber, M., Kim, S., Patterson, N., Rooney, K., & Searles, C. D. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00521.2013 · Cited by 73 · see citing works
Improved repair of dermal wounds in mice lacking micro<scp>RNA</scp>‐155
van Solingen, C., Araldi, E., Chamorro‐Jorganes, A., Fernández‐Hernando, C., & Suárez, Y. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12255 · Cited by 66 · see citing works
Strong reduction of AGO2 expression in melanoma and cellular consequences
Völler, D., Reinders, J., Meister, G., & Bosserhoff, A. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.646 · Cited by 62 · see citing works
Loss of Heterozygosity at 2q37 in Sporadic Wilms' Tumor: Putative Role for miR-562
Drake, K. M., Ruteshouser, E. C., Natrajan, R., Harbor, P. C., Wegert, J., Gessler, M., Pritchard‐Jones, K., Grundy, P. E., Dome, J. S., Huff, V., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1065 · Cited by 58 · see citing works
miRNA-548c: A specific signature in circulating PBMCs from dilated cardiomyopathy patients
Gupta, M. K., Halley, C. M., Duan, Z.-H., Lappé, J. M., Viterna, J., Jana, S., Augoff, K., Mohan, M. L., Vasudevan, N. T., Na, J., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.05.011 · Cited by 53 · see citing works
Up-regulation of Ago2 expression in gastric carcinoma
Zhang, J., Fan, X., Wang, C., Liu, B., Li, Q., & Zhou, X. (2013) · Medical Oncology · doi:10.1007/s12032-013-0628-2 · Cited by 49 · see citing works
Over-expression of miR375 reduces glucose-induced insulin secretion in Nit-1 cells
Xia, H.-Q., Pan, Y., Peng, J., & Lu, G. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-9973-9 · Cited by 39 · see citing works
The Role of MicroRNAs in Kidney Disease
Mukhadi, S., Hull, R., Mbita, Z., & Dlamini, Z. (2015) · Non-Coding RNA · doi:10.3390/ncrna1030192 · Cited by 39 · see citing works
MicroRNAs: The Underlying Mediators of Pathogenetic Processes in Vascular Complications of Diabetes
Ruiz, M. A., & Chakrabarti, S. K. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.003 · Cited by 32 · see citing works
Dahan, D., Ekman, M., Larsson‐Callerfelt, A., Turczyńska, K. M., Boettger, T., Braun, T. W., Swärd, K., & Albinsson, S. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00250.2014 · Cited by 32 · see citing works
MicroRNAs in cardiovascular disease
Elton, T. S., Khan, M., & Terentyev, D. A. (2011) · F1000 Medicine Reports · doi:10.3410/m3-10 · Cited by 20 · see citing works
An Overview of Blood Pressure Regulation Associated with the Kidney
Suzuki, H., & Saruta, T. (2004) · KARGER eBooks · doi:10.1159/000078708 · Cited by 11 · see citing works
Cloning MicroRNAs From Mammalian Tissues
Michael, M. (2006) · Humana Press eBooks · doi:10.1385/1-59745-123-1:189 · Cited by 9 · see citing works
miRNAs Targeting and Targeting miRNAs
Wang, Z. (2009) · Springer eBooks · doi:10.1007/978-3-642-00489-6_1 · Cited by 3 · see citing works
MicroRNAs in cardiovascular disease
Dimmeler, S. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2011.08.068 · Cited by 3 · see citing works
miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs
Mourelatos, Z., Dostie, J., Paushkin, S., Sharma, A., Charroux, B., Abel, L., Rappsilber, J., Mann, M., & Dreyfuss, G. (2002) · Genes & Development · doi:10.1101/gad.974702
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799
Flagged first, then by citations
2 of the 172 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
O'Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00402 · Cited by 5,287 · see citing works
“Aberrant expression of miRNAs is associated with many human diseases (19, 20).”
BackgroundAn overview of microRNAs: Biology, functions, therapeutics, and analysis methods
Saliminejad, K., Khorshid, H. R. K., Fard, S. S., & Ghaffari, S. H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27486 · Cited by 2,047 · see citing works
“Alteration in miRNA expression pattern have been demonstrated in a variety of human disease including cancer, cardiovascular disease, metabolic disease, diabetes, and viral pathogenesis, and miRNA dysregulation as a causal factor in disease progression have been confirmed (Paul et al., 2018).”
BackgroundRole of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies
Khan, A. S., Ahmed, E. I., Elareer, N. R., Junejo, K., Steinhoff, M. S., & Shahab Uddin, M. S. (2019) · Cells · doi:10.3390/cells8080840 · Cited by 296 · see citing works
“Given this omnipresent role in gene regulation, it is not surprising that misregulation of individual miRNAs can have dire consequences, contributing to a variety of diseases and afflictions in humans [6].”
Emerging roles of exosomal miRNAs in diabetes mellitus
He, X., Kuang, G., Wu, Y., & Ou, C. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.468 · Cited by 232 · see citing works
Role of microRNAs in obesity and obesity-related diseases
Iacomino, G., & Siani, A. (2017) · Genes & Nutrition · doi:10.1186/s12263-017-0577-z · Cited by 225 · see citing works
Bavelloni, A., Ramazzotti, G., Poli, A., Piazzi, M., Focaccia, E., Blalock, W. L., & Faenza, I. (2017) · Anticancer Research · doi:10.21873/anticanres.12107 · Cited by 210 · see citing works
Cheng, H., Chang, S., Xu, R., Chen, L., Song, X., Wu, J., Qian, J., Zou, Y., & Ma, J. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01737-0 · Cited by 187 · see citing works
“We directly overexpressed miR-210 in cardiomyocytes to compare the difference between the endogenous and induced miR-210 [34].”
BackgroundPhysical exercise and epigenetic modifications in skeletal muscle
Widmann, M., Nieß, A. M., & Munz, B. (2019) · Sports Medicine · doi:10.1007/s40279-019-01070-4 · Cited by 165 · see citing works
The Role of microRNAs in Ovarian Granulosa Cells in Health and Disease
Tu, J., Cheung, H., Chan, C. L. K., & Chan, W. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00174 · Cited by 152 · see citing works
“They are estimated to regulate mRNA translation of more than 70% of the protein-coding genes and are widely involved in both the normal and diseased states (17).”
BackgroundqPCR-Based Methods for Expression Analysis of miRNAs
Forero, D. A., González‐Giraldo, Y., Castro‐Vega, L. J., & Barreto, G. E. (2019) · BioTechniques · doi:10.2144/btn-2019-0065 · Cited by 148 · see citing works
The Role of Exosomal microRNAs and Oxidative Stress in Neurodegenerative Diseases
Wang, X., Zhou, Y., Gao, Q., Ping, D., Wang, Y., Wu, W., Xu, L., Fang, Y., Zhang, J., & Shao, A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3232869 · Cited by 149 · see citing works
“neurodegeneration disease, and some of them was proved to be involved in progression of diseases [90, 91].”
BackgroundThe regulatory role of micro RNA s in angiogenesis‐related diseases
Sun, L., Li, W., Lei, F., & Li, X. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13700 · Cited by 143 · see citing works
“Moreover, miR-21, miR-181c and miR-1179 are significantly upregulated in patients with proliferative DR (PDR) compared with non-proliferative DR (NPDR),(216) suggesting that miRNAs may serve as potential biomarkers for detecting the progression of PDR from NPDR.(213) Functionally, miR-21 is highly related to angiogene…”
BackgroundMonfared, H., Jahangard, Y., Nikkhah, M., Mirnajafi-Zadeh, J., & Mowla, S. J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00782 · Cited by 123 · see citing works
Xue, M., Cheng, Y., Han, F., Chang, Y., Yang, Y., Li, X., Chen, L., Lu, Y., Sun, B., & Chen, L. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.24032 · Cited by 112 · see citing works
“MiRNAs play a crucial part in numerous diseases, including diabetes, cardiovascular diseases, kidney diseases and cancers[34].”
BackgroundMicroRNA biogenesis, gene silencing mechanisms and role in breast, ovarian and prostate cancer
Khan, S., Ayub, H., Khan, T., & Wahid, F. (2019) · Biochimie · doi:10.1016/j.biochi.2019.09.001 · Cited by 105 · see citing works
LncRNAs: key players and novel insights into diabetes mellitus
He, X., Ou, C., Xiao, Y., Han, Q., Li, H., & Zhou, S. (2017) · Oncotarget · doi:10.18632/oncotarget.19921 · Cited by 103 · see citing works
“Inspiringly, the morbidity and mortality caused by DM can be reduced by regular screening, early detection, and appropriate treatment of chronic complications [23, 24].”
BackgroundMicroglia exosomal miRNA-137 attenuates ischemic brain injury through targeting Notch1
Zhang, D., Cai, G., Liu, K., Zhuang, Z., Jia, K., Pei, S., Wang, X., Wang, H., Xu, S., Cui, C., et al. (2021) · Aging · doi:10.18632/aging.202373 · Cited by 99 · see citing works
Plant virus-based materials for biomedical applications: Trends and prospects
Eiben, S., Koch, C., Altintoprak, K., Southan, A., Tovar, G. E. M., Laschat, S., Weiss, I. M., & Wege, C. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.08.011 · Cited by 96 · see citing works
Song, X., Wei, W., Cheng, W., Zhu, H., Wang, W., Dong, H., & Li, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.939532 · Cited by 95 · see citing works
“Previous reports have demonstrated that the expression of circulating microRNAs (miRNAs) is highly sensitive to physiological and pathological stimuli (Paul et al., 2018).”
BackgroundmiRNAs as Influencers of Cell–Cell Communication in Tumor Microenvironment
Conti, I., Varano, G., Simioni, C., Laface, I., Milani, D., Rimondi, E., & Neri, L. M. (2020) · Cells · doi:10.3390/cells9010220 · Cited by 91 · see citing works
“MiRNAs are both pleiotropic and redundant, and it has been proposed that at least 30% of human genes are regulated by the cooperation among miRNAs: one mRNA can be recognize by different miRNAs and one miRNA can recognize different mRNAs [100].”
BackgroundNrf2 Pathway in Age-Related Neurological Disorders: Insights into MicroRNAs
Paladino, S., Conte, A., Caggiano, R., Pierantoni, G. M., & Faraonio, R. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491465 · Cited by 92 · see citing works
Foo, J. B., Looi, Q. H., How, C. W., Lee, S. H., Al-Masawa, M. E., Chong, P. P., & Law, J. X. (2021) · Pharmaceuticals · doi:10.3390/ph14111093 · Cited by 89 · see citing works
Extracellular Vesicle Proteins and MicroRNAs as Biomarkers for Traumatic Brain Injury
Guedes, V. A., Devoto, C., Leete, J., Sass, D., Acott, J. D., Mithani, S., & Gill, J. M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00663 · Cited by 85 · see citing works
“MiRNAs have been linked to inflammation in several human diseases (197).”
BackgroundGu, S., Sun, D., Dai, H., & Zhang, Z. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.04.018 · Cited by 78 · see citing works
Woo, I., Christenson, L. K., Gunewardena, S., Ingles, S. A., Thomas, S. A., Ahmady, A., Chung, K., Bendikson, K. A., Paulson, R. J., & McGinnis, L. K. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-018-1239-9 · Cited by 78 · see citing works
Shaheen, N., Shaheen, A., Osama, M., Nashwan, A. J., Bharmauria, V., & Flouty, O. E. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00791-2 · Cited by 77 · see citing works
Exosomal MicroRNAs Released by Activated Astrocytes as Potential Neuroinflammatory Biomarkers
Gayen, M., Bhomia, M., Balakathiresan, N. S., & Knollmann-Ritschel, B. E. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072312 · Cited by 76 · see citing works
“Emerging evidence emphasizes the key role of miRNAs in regulating neuroinflammation, as is commonly observed in neurodegenerative diseases and CNS injuries [5].”
BackgroundMalczewska, A., Kidd, M. S., Matar, S., Kos‐Kudła, B., & Modlin, I. M. (2018) · Neuroendocrinology · doi:10.1159/000487326 · Cited by 74 · see citing works
Advances in Understanding the Molecular Basis of the Mediterranean Diet Effect
Corella, D., Coltell, Ó., Macián, F., & Ordovás, J. M. (2018) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-032217-020802 · Cited by 74 · see citing works
“For example, the miR-1, miR-133a, miR-133b and miR-499-5p are high in plasma following an acute myocardial infarction (Paul et al, 2017).”
BackgroundNanomedicine and epigenome. Possible health risks
Smolková, B., Dušinská, M., & Gábelová, A. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.07.020 · Cited by 70 · see citing works
“Deregulation of miRNAs has been implicated not only in tumorigenesis, but also in neurological, cardiovascular, developmental and other diseases (Esteller 2011, Paul et al. 2017).”
BackgroundBhatia, S., Monkman, J. H., Toh, A. K. L., Nagaraj, S. H., & Thompson, E. W. (2017) · Biochemical Journal · doi:10.1042/bcj20160782 · Cited by 73 · see citing works
Yang, Z., Liu, X., Xu, H., Teschendorff, A. E., Xu, L., Li, J., Fu, M., Liu, J., Zhou, H., Wang, Y., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06488-9 · Cited by 63 · see citing works
“Aberrant expression of miRNAs is associated with many human diseases 11,12 .”
Zhang, J., Cai, W., Fan, Z., Yang, C., Wang, W., Xiong, M., Ma, C., & Yang, J. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.023 · Cited by 64 · see citing works
Epigenetic Aspects of Engineered Nanomaterials: Is the Collateral Damage Inevitable?
Gedda, M. R., Babele, P. K., Zahra, K., & Madhukar, P. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00228 · Cited by 62 · see citing works
Pre-eclampsia predictive ability of maternal miR-125b: a clinical and experimental study
Licini, C., Avellini, C., Picchiassi, E., Mensa’, E., Fantone, S., Ramini, D., Tersigni, C., Tossetta, G., Castellucci, C., Tarquini, F., et al. (2020) · Translational research · doi:10.1016/j.trsl.2020.07.011 · Cited by 61 · see citing works
Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs
Sankrityayan, H., Kulkarni, Y. A., & Gaikwad, A. B. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.01.043 · Cited by 62 · see citing works
MicroRNA Networks in Pancreatic Islet Cells: Normal Function and Type 2 Diabetes
Eliasson, L., & Esguerra, J. L. S. (2020) · Diabetes · doi:10.2337/dbi19-0016 · Cited by 58 · see citing works
“Therefore, perturbed miRNA expression is often associated with development of human diseases (2), including type 2 diabetes (T2D) and associated complications.”
BackgroundGlucocorticoid Receptor Signaling in Diabetes
Kokkinopoulou, I., Diakoumi, A., & Moutsatsou, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011173 · Cited by 60 · see citing works
“Dysregulation of miRNAs has been associated with a variety of diseases, including cardiovascular disease, kidney disease, and cancer [163].”
BackgroundApplications of miRNAs in cardiac development, disease progression and regeneration
Pang, J. K. S., Phua, Q. H., & Soh, B.-S. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1451-2 · Cited by 56 · see citing works
“Scientific interest in miRNA lies in its contribution to development [3], dysregulation in diseases [4] and therefore potential as a disease biomarker and therapeutic [5, 6].”
BackgroundTorres, L., Cogliati, B., & Otton, R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4168380 · Cited by 57 · see citing works
“In the last decade, the discovery of epigenetic mechanisms of small noncoding RNAs known as microRNAs (miRNAs) has emerged as potential therapeutic targets for several diseases [15].”
BackgroundLeontariti, M., Avgeris, M., Katsarou, M., Drakoulis, N., Siatouni, A., Verentzioti, A., Alexoudi, A., Fytraki, A., Patrikelis, P., Vassilacopoulou, D., et al. (2020) · Epilepsia · doi:10.1111/epi.16502 · Cited by 58 · see citing works
Tang, Y., Cui, G., Liu, H., Han, Y., Cai, C., Feng, Z., Shen, H., & Zeng, S. (2024) · 癌症:英文版 · doi:10.1002/cac2.12546 · Cited by 56 · see citing works
“This may be the mechanism by which miRNAs exert their effects. miRNA has been shown to be an important factor in the development of a variety of diseases, including cancer, cardiovascular disease, metabolic endocrine disorders, etc [112].”
BackgroundSørensen, A. E., van Poppel, M. N. M., Desoyé, G., Damm, P., Simmons, D. S., Jensen, D., Dalgaard, L. T., & The DALI Core Investigator Group (2021) · Cells · doi:10.3390/cells10010170 · Cited by 55 · see citing works
“By post-transcriptional gene regulation, miRNAs modulate various physiological processes and their dysregulation is often implicated in disease [20,21].”
BackgroundShen, C., Tao, C., Zhang, A., Li, X., Guo, Y., Wei, H., Yin, Q., Li, Q., & Jin, P. (2021) · Bioengineered · doi:10.1080/21655979.2021.1997077 · Cited by 53 · see citing works
“For instance, miR-93, belonging to the miR-106b-25 family, functions as a tumor suppressor and inhibits the invasion and metastasis of tumor cells [40].”
BackgroundRetractedOpposing roles of microRNA Argonautes during Caenorhabditis elegans aging
Aalto, A. P., Nicastro, I. A., Broughton, J. P., Chipman, L. B., Schreiner, W. P., Chen, J. S., & Pasquinelli, A. E. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007379 · Cited by 52 · see citing works
miRNAs as Therapeutic Tools in Alzheimer’s Disease
Lee, C. Y., Ryu, I. S., Ryu, J., & Cho, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313012 · Cited by 51 · see citing works
Genetically Engineered-MSC Therapies for Non-unions, Delayed Unions and Critical-size Bone Defects
Freitas, J., Santos, S. G., Gonçalves, R. M., Teixeira, J. H., Barbosa, M. A., & Almeida, M. I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143430 · Cited by 51 · see citing works
“Specifically, miRNAs are a class of small ncRNAs that act as post-transcriptional regulators of gene expression, generally by binding to 3’ UTR of the target messenger RNA (mRNA) [29,31], and that have been associated with the regulation of several cell biology processes, including apoptosis, proliferation, migration,…”
BackgroundFavero, A., Segatto, I., Perin, T., & Belletti, B. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1659 · Cited by 52 · see citing works
“The complex roles played by miRNA in normal and pathological conditions have been extensively and exhaustively reviewed elsewhere (Haneklaus et al., 2013; O'Connell et al., 2010; Paul et al., 2018; Peng & Croce, 2016; Tan et al., 2018).”
BackgroundMicroRNA expression profile in retina and choroid in oxygen-induced retinopathy model
Desjarlais, M., Rivera, J. C., Lahaie, I., Cagnone, G., Wirt, M., Omri, S., & Chemtob, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218282 · Cited by 50 · see citing works
Durur, D. Y., Tastan, B., Tüfekçi, K. U., Olcum, M., Uzuner, H., Karakülah, G., Yener, G., & Genç, Ş. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02012-y · Cited by 49 · see citing works
A comprehensive review on oncogenic miRNAs in breast cancer
Nurzadeh, M., Naemi, M., & Hasani, S. S. (2021) · Journal of Genetics · doi:10.1007/s12041-021-01265-7 · Cited by 49 · see citing works
Members of the microRNA-200 family are promising therapeutic targets in cancer
Chen, Y., & Zhang, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4488 · Cited by 48 · see citing works
“It has been demonstrated that the altered expression of miR is associated with tumorigenesis and the progression of different types of cancer (5,6).”
MicroRNA Schizophrenia: Etiology, Biomarkers and Therapeutic Targets.
Zhang, H., Du, Y., Chen, L., Yuan, Z.-Q., & Cheng, Y. (2023) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105064 · Cited by 43 · see citing works
Nguyen, N. H. A., & Falagan-Lotsch, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044109 · Cited by 47 · see citing works
microRNA-184 in the landscape of human malignancies: a review to roles and clinical significance
Fattahi, M., Rezaee, D., Fakhari, F., Najafi, S., Zarch, S. M. A., Beyranvand, P., Rashidi, M. A., Bagheri‐Mohammadi, S., Rarani, F. Z., Bakhtiari, M., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01718-1 · Cited by 46 · see citing works
Chen, Y., Yang, Y., Fan, X.-L., Lin, P., Yang, H., Chen, X., & Xu, X. (2019) · Bioscience Reports · doi:10.1042/bsr20181108 · Cited by 46 · see citing works
Behura, A., Mishra, A., Chugh, S., Mawatwal, S., Kumar, A., Manna, D., Mishra, A., Singh, R., & Dhiman, R. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.06.001 · Cited by 44 · see citing works
Role of microRNAs in Venous Thromboembolism
Morelli, V. M., Brækkan, S. K., & Hansen, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072602 · Cited by 46 · see citing works
“Given the stability and presence in various body fluids, miRNAs have emerged as a promising class of biomarkers for many diseases including cancer and cardiovascular diseases [14].”
BackgroundHsa_circ_0011385 accelerates the progression of thyroid cancer by targeting miR-361-3p
Xia, F., Chen, Y., Jiang, B., Bai, N., & Li, X. (2020) · Cancer Cell International · doi:10.1186/s12935-020-1120-7 · Cited by 45 · see citing works
Zhao, G. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2018-105387 · Cited by 44 · see citing works
Review of databases for experimentally validated human microRNA–mRNA interactions
Kariuki, D., Asam, K. R., Aouizerat, B. E., Lewis, K., Florez, J. C., & Flowers, E. (2023) · Database · doi:10.1093/database/baad014 · Cited by 44 · see citing works
“MiR dysregulation has been investigated in different diseases, including cardiovascular disease, metabolic disorders, vascular diseases, neurological disorders and cancers (4, 5).”
BackgroundSex Differences in Airway Remodeling and Inflammation: Clinical and Biological Factors
Ekpruke, C. D., & Silveyra, P. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2022.875295 · Cited by 49 · see citing works
Nadeem, R. I., Aboutaleb, A. S., Younis, N. S., & Ahmed, H. I. (2023) · Toxics · doi:10.3390/toxics11010048 · Cited by 42 · see citing works
MicroRNA: role in macrophage polarization and the pathogenesis of the liver fibrosis
Yu, W., Wang, S., Wang, Y., Chen, H., Nie, H., Liu, L., Zou, X., Gong, Q., & Zheng, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1147710 · Cited by 41 · see citing works
Li, X., Peng, B., Zhu, X., Wang, P., Sun, K., Lei, X., He, H., Tian, Y., Mo, S., Zhang, R., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28916 · Cited by 41 · see citing works
Circulating miRNAs, Small but Promising Biomarkers for Autism Spectrum Disorder
Salloum‐Asfar, S., Satheesh, N. J., & Abdulla, S. A. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00253 · Cited by 41 · see citing works
Pathogenetic analysis of polycystic ovary syndrome from the perspective of omics
Pei, C.-Z., Jin, L., & Baek, K. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112031 · Cited by 39 · see citing works
MicroRNA-1270 modulates papillary thyroid cancer cell development by regulating SCAI
Yi, T., Zhou, X., Sang, K., Zhou, J., & Ge, L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.150 · Cited by 39 · see citing works
Klimova, N., Long, A. N., & Kristián, T. (2017) · Translational Stroke Research · doi:10.1007/s12975-017-0569-8 · Cited by 36 · see citing works
“This complex binds mRNAs by imperfect base pairing and ultimately represses translation [138].”
New Possibilities in the Therapeutic Approach to Alzheimer’s Disease
Doroszkiewicz, J., & Mroczko, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168902 · Cited by 39 · see citing works
Circulating miRNA Profiling in Plasma Samples of Ovarian Cancer Patients
Penyige, A., Márton, É., Soltész, B., Szilágyi, M., Póka, R., Lukács, J., Széles, L., & Nagy, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184533 · Cited by 36 · see citing works
“MiRNAs are promiscuous post-transcriptional regulators, due to their short “seed” sequence, a miRNA can interact with a large number of mRNAs, that way miRNAs are involved in the regulation of almost all important cellular, developmental, and pathological processes [12].”
BackgroundImperatore, J. A., Then, M. L., McDougal, K. B., & Mihailescu, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030767 · Cited by 37 · see citing works
“The importance of regulating miRNA levels has been demonstrated in a multitude of studies, with dysregulated levels being associated with various diseases, such as AD [31], Down syndrome [32], and many cancers [33].”
BackgroundLi, Y., Liu, Y.-D., Zhou, X., Chen, S., Chen, X., Zhe, J., Zhang, J., Zhang, Q., & Chen, Y.-X. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110540 · Cited by 36 · see citing works
MicroRNA in localized scleroderma: a review of literature
Wolska-Gawron, K., Bartosińska, J., & Krasowska, D. (2019) · Archives of Dermatological Research · doi:10.1007/s00403-019-01991-0 · Cited by 36 · see citing works
Cione, E., Cannataro, R., Gallelli, L., Sarro, G. D., & Caroleo, M. C. (2021) · Pharmaceuticals · doi:10.3390/ph14121257 · Cited by 36 · see citing works
“Therefore, consequences that can be recognized as diabetic are: (i) retinopathy, (ii) macro-vascular complications, (iii) nephropathy, (iv) cardiomyopathy, and (v) foot ulcers [48].”
BackgroundConceptos básicos en biología molecular relacionados con la genética y la epigenética
Corella, D., & Ordovás, J. M. (2017) · Revista Española de Cardiología · doi:10.1016/j.recesp.2017.02.034 · Cited by 35 · see citing works
Can miR-145-5p be used as a marker in diabetic patients?
Shahrokhi, S. Z., Saeidi, L., Sadatamini, M., Jafarzadeh, M., Rahimipour, A., & Kazerouni, F. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1762657 · Cited by 35 · see citing works
Epitranscriptomics: A New Layer of microRNA Regulation in Cancer
Paolis, V. D., Lorefice, E., Orecchini, E., Carissimi, C., Laudadio, I., & Fulci, V. (2021) · Cancers · doi:10.3390/cancers13133372 · Cited by 36 · see citing works
“Changes in the miRNA expression levels have been associated with a wide range of human diseases, including diabetes, cardiovascular and kidney disease and cancer [3,4].”
Ahmad, A. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.09.001 · Cited by 35 · see citing works
Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future
Komarnicki, P., Musiałkiewicz, J., Stańska, A., Maciejewski, A., Gut, P., Mastorakos, G. P., & Ruchała, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195542 · Cited by 35 · see citing works
MicroRNA mediated regulation of immunity against gram-negative bacteria
Keck, J., Gupta, R., Christenson, L. K., & Arulanandam, B. P. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2017.1347649 · Cited by 34 · see citing works
Çelik, E., Cemali, Ö., Şahin, T. Ö., Deveci, G., BİÇER, N. Ç., Hirfanoğlu, İ. M., Ağagündüz, D., & Budán, F. (2024) · Nutrients · doi:10.3390/nu16203519 · Cited by 35 · see citing works
Yang, Z., Wen, Z.-B., Peng, X., Chai, Y., Liang, W., & Yuan, R. (2019) · Chemical Communications · doi:10.1039/c9cc01850f · Cited by 34 · see citing works
MicroRNA-299-3p suppresses proliferation and invasion by targeting VEGFA in human colon carcinoma
Wang, J., Jiang, J., Li, Y., Wang, Y.-L., & Dai, Y. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.030 · Cited by 33 · see citing works
Gupta, H., Sahu, P. K., Pattnaik, R., Mohanty, A., Majhi, M., Mohanty, D., Pirpamer, L., Hoffmann, A., Mohanty, S., & Wassmer, S. C. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.396 · Cited by 33 · see citing works
Epigenetic regulation of pediatric and neonatal immune responses
Bermick, J., & Schaller, M. A. (2021) · Pediatric Research · doi:10.1038/s41390-021-01630-3 · Cited by 32 · see citing works
“MicroRNAs are associated with many developmental processes and have been proposed as biomarkers in many disease states.(8,9) Figure 1 provides a visual representation of these different epigenetic mechanisms.”
BackgroundDuval, C., Wyse, B. A., Tsang, B. K., & Librach, C. L. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01480-7 · Cited by 33 · see citing works
“…play an essential role in a variety of biological processes and an aberrant expression of miRNAs is associated with many human diseases [93, 95, 96]. sncRNAs in EVs have been more extensively studied in the recent years, however more than 90% of circulating miRNAs are outside EVs and are…”
BackgroundMahapatra, K., Banerjee, S., De, S., Mitra, M., Roy, P., & Roy, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.671698 · Cited by 32 · see citing works
MicroRNA: Potential biomarker and target of therapy in acute lung injury
Jiang, Z.-F., Zhang, L., & Shen, J. (2020) · Human & Experimental Toxicology · doi:10.1177/0960327120926254 · Cited by 31 · see citing works
“Third, the expression of miRNAs changes in different kinds of diseases before presenting their subsequent effects.(68) Fourth, the expression profiles for most miRNAs are generally independent of sex; however, some may be influenced by specific factors, such as age and disease.”
BackgroundThe human box C/D snoRNA U3 is a miRNA source and miR-U3 regulates expression of sortin nexin 27
Lemus-Diaz, N., Ferreira, R. R., Bohnsack, K. E., Gruber, J., & Bohnsack, M. T. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa549 · Cited by 31 · see citing works
A hidden threshold in motor neuron gene networks revealed by modulation of miR-218 dose
Amin, N. D., Senturk, G., Costaguta, G., Driscoll, S. P., O’Leary, B., Bonanomi, D., & Pfaff, S. L. (2021) · Neuron · doi:10.1016/j.neuron.2021.07.028 · Cited by 31 · see citing works
Han, Q., Wang, M., Dong, X., Wei, F., Luo, Y., & Sun, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.985815 · Cited by 31 · see citing works
Dave, B. P., Shah, Y. B., Maheshwari, K. G., Mansuri, M. K. A., Prajapati, B., Postwala, H. I., & Chorawala, M. R. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01408-7 · Cited by 32 · see citing works
“Therefore, it could be proposed that a variety of human disorders, including AD, can be influenced by the dysregulation of miRNAs and that targeting the miRNAs can lead to successful therapeutic outcomes (Paul et al. 2018).”
BackgroundBiological functions and affected signaling pathways by Long Non-Coding RNAs in the immune system
Almanghadim, H. G., Karimi, B., Valizadeh, S., & Ghaedi, K. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.09.001 · Cited by 30 · see citing works
“Furthermore, in the population with a high risk for T1DM, circulating biomarkers could be predictors of stress, dysfunction and death of β -cell in the early pre-symptomatic phase, which suggests that immune-modulatory therapy initiated to help maintain β cell mass effectively [302 – 304].”
BackgroundRuan, D., Liu, Y., Wang, X., Yang, D., & Sun, Y. (2019) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2019.104279 · Cited by 30 · see citing works
Roffel, M. P., Maes, T., Brandsma, C., van den Berge, M., Vanaudenaerde, B. M., Joos, G., Brusselle, G., Heijink, I. H., & Bracke, K. R. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00252.2021 · Cited by 30 · see citing works
“MiRNAs are involved in a wide variety of biological processes, including regulation of inflammatory responses (7), and have been implicated in the pathogenesis of several diseases (8).”
Duan, Y., Veksler‐Lublinsky, I., & Ambros, V. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110745 · Cited by 29 · see citing works
“miRNAs regulate an estimated 60% of human genes, and the dysfunction of miRNAs is implicated in multiple diseases (Friedman et al., 2009; Paul et al., 2018).”
BackgroundThe Complex Interaction between P53 and miRNAs Joins New Awareness in Physiological Stress Responses
Capaccia, C., Diverio, S., Zampini, D., & Guelfi, G. (2022) · Cells · doi:10.3390/cells11101631 · Cited by 29 · see citing works
“A plethora of recent studies has demonstrated that cell-free miRNA, called circulating miRNAs (cmiRNAs), represent the next generation of clinical, non-invasive, biomarkers for many pathologies [25].”
BackgroundDeng, J., Wang, H., Liang, Y., Zhao, L., Li, Y., Yan, Y., Zhao, H., Zhang, X., & Zou, F. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110517 · Cited by 29 · see citing works
- Authors
- Paul, P., Chakraborty, A., Sarkar, D., Langthasa, M., Rahman, M., Bari, M., Singha, R. S., Malakar, A. K., & Chakraborty, S.
- Affiliations
- Assam University (IN)
- Corresponding author
- Chakraborty, Supriyo
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2017-04-27
- Volume
- 233
- Issue
- 3
- Pages
- 2007-2018
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2586411032
- Cited by
- 420
- References
- 172
- Citations by year
- 2026: 9 · 2025: 36 · 2024: 44 · 2023: 44 · 2022: 61 · 2021: 64 · 2020: 69 · 2019: 53 · 2018: 24 · 2017: 16
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cellular Physiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Assam University, Silchar
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Plant Molecular Biology Research
- Keywords
- microRNA, non-coding RNA, gene regulatory networks, pathogenesis, diabetes mellitus, cardiovascular disease, kidney disease, cancer, disease diagnosis, therapeutic target
- MeSH terms
- Diabetes Mellitus, Humans, Kidney Diseases, Cardiomyopathies, Neoplasms, MicroRNAs, Atherosclerosis, Gene Regulatory Networks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review